SEC Form 4 · accession 0001794362-26-000004
Vistagen Therapeutics, Inc. · VTGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nick B. Tressler
Officer — Chief Financial Officer
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 4:17 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001411685
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2026 | A | 11,712 | $0.1921 | A | 11,712 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).